The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
APOBEC proteins and intrinsic resistance to HIV-1 infection
Open accessAbstract
Members of the APOBEC family of cellular polynucleotide cytidine deaminases, most notably APOBEC3G and APOBEC3F, are potent inhibitors of HIV-1 infection. Wild type HIV-1 infections are largely spared from APOBEC3G/F function through the action of the essential viral protein, Vif. In the absence of Vif, APOBEC3G/F are encapsidated by budding virus particles leading to excessive cytidine (C) to uridine (U) editing of negative sense reverse transcripts in newly infected cells. This registers as guanosine (G) to adenosine (A) hypermutations in plus-stranded cDNA. In addition to this profoundly debilitating effect on genetic integrity, APOBEC3G/F also appear to inhibit viral DNA synthesis by impeding the translocation of reverse transcriptase along template RNA. Because the functions of Vif and APOBEC3G/F proteins oppose each other, it is likely that fluctuations in the Vif–APOBEC balance may influence the natural history of HIV-1 infection, as well as viral sequence diversification and evolution. Given Vif's critical role in suppressing APOBEC3G/F function, it can be argued that pharmacologic strategies aimed at restoring the activity of these intrinsic anti-viral factors in the context of infected cells in vivo have clear therapeutic merit, and therefore deserve aggressive pursuit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
Chiu, Y.-L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., & Greene, W. C. (2005) · Nature · doi:10.1038/nature03493 · Cited by 439
RetractedIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Self-citationKeele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationInduction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O., & Honjo, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18470 · Cited by 1,176
Molecular Mechanisms of Antibody Somatic Hypermutation
Di Noia, J. M., & Neuberger, M. S. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061705.090740 · Cited by 1,106
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
Self-citationSpecies-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
HIV-1 replication is controlled at the level of T cell activation and proviral integration.
Stevenson, M., Stanwick, T. L., Dempsey, M. P., & Lamonica, C. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08274.x · Cited by 800
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
Stopak, K., de Noronha, C., Yonemoto, W., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 732
Retroviral restriction by APOBEC proteins
Harris, R. S., & Liddament, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1489 · Cited by 654
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
Self-citationRNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen-Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 603
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 597
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Self-citationMolecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein
Teng, B., Burant, C. F., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 536
Evolution of the AID/APOBEC Family of Polynucleotide (Deoxy)cytidine Deaminases
Conticello, S. G., Thomas, C. J. F., Petersen-Mahrt, S. K., & Neuberger, M. S. (2005) · Molecular Biology and Evolution · doi:10.1093/molbev/msi026 · Cited by 498
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
Self-citationThe HIV A (sor) gene product is essential for virus infectivity
Strebel, K., Daugherty, D., Clouse, K., Cohen, D., Folks, T., & Martin, M. A. (1987) · Nature · doi:10.1038/328728a0 · Cited by 479
Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., & Gabuzda, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 474
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Conticello, S. G., Harris, R. S., & Neuberger, M. S. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.034 · Cited by 469
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 454
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 446
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
von Schwedler, U., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 444
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons
Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., & Weitzman, M. D. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.031 · Cited by 389
Maschera, B., Darby, G., Palú, G., Wright, L. L., Tisdale, M., Myers, R., Blair, E. D., & Furfine, E. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33231 · Cited by 381
Cytidine Deaminase. The 2·3 Å Crystal Structure of an Enzyme: Transition-state Analog Complex
Betts, L., Xiang, S., Short, S. A., Wolfenden, R. V., & Carter, C. W. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1018 · Cited by 374
The sor Gene of HIV-1 Is Required for Efficient Virus Transmission in Vitro
Fisher, A. G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R. C., & Wong-Staal, F. (1987) · Science · doi:10.1126/science.3497453 · Cited by 357
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., & Schwartz, O. (2005) · Nature · doi:10.1038/nature03238 · Cited by 346
Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions
Vartanian, J.-P., Guétard, D., Henry, M., & Wain-Hobson, S. (2008) · Science · doi:10.1126/science.1153201 · Cited by 331
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Bishop, K. N., Verma, M., Kim, E.-Y., Wolinsky, S. M., & Malim, M. H. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000231 · Cited by 328
Self-citationDeaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Iwatani, Y., Chan, D. S. B., Wang, F., Stewart-Maynard, K., Sugiura, W., Gronenborn, A. M., Rouzina, I., Williams, M. C., Musier-Forsyth, K., & Levin, J. G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm750 · Cited by 321
Schröfelbauer, B., Chen, D., & Landau, N. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307132101 · Cited by 311
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
Self-citationAPOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 306
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305
Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X., & Yu, X.-F. (2004) · Genes & Development · doi:10.1101/gad.1250204 · Cited by 302
Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., & Gabuzda, D. (2004) · Genes & Development · doi:10.1101/gad.1249904 · Cited by 296
Bogerd, H. P., Doehle, B. P., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
Bishop, K. N., Holmes, R. K., & Malim, M. H. (2006) · Journal of Virology · doi:10.1128/jvi.00839-06 · Cited by 293
Self-citationAPOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281
APOBEC-mediated viral restriction: not simply editing?
Holmes, R. K., Malim, M. H., & Bishop, K. N. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.01.004 · Cited by 280
Self-citationEvidence for a newly discovered cellular anti-HIV-1 phenotype
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M., & Malim, M. H. (1998) · Nature Medicine · doi:10.1038/3987 · Cited by 280
Self-citationGallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., & Malim, M. H. (2007) · Journal of Virology · doi:10.1128/jvi.02287-06 · Cited by 279
Self-citationMbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00272-07 · Cited by 274
Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., & Pathak, V. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405761200 · Cited by 268
Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family
Dang, Y., Wang, X., Esselman, W. J., & Zheng, Y.-H. (2006) · Journal of Virology · doi:10.1128/jvi.01123-06 · Cited by 255
Simon, V., Zennou, V., Murray, D., Huang, Y., Ho, D. D., & Bieniasz, P. D. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010006 · Cited by 249
APOBEC-Mediated Editing of Viral RNA
Bishop, K. N., Holmes, R. K., Sheehy, A. M., & Malim, M. H. (2004) · Science · doi:10.1126/science.1100658 · Cited by 247
Self-citationMadani, N., & Kabat, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10251-10255.1998 · Cited by 245
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition
Chiu, Y.-L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., & Greene, W. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604524103 · Cited by 244
A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action
Mangeat, B., Turelli, P., Liao, S., & Trono, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400060200 · Cited by 239
Xu, H., Svarovskaia, E. S., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., & Pathak, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400830101 · Cited by 238
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, B. P., Schäfer, A., & Cullen, B. R. (2005) · Virology · doi:10.1016/j.virol.2005.06.005 · Cited by 229
Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus
Desrosiers, R. C., Lifson, J. D., Gibbs, J. S., Czajak, S. C., Howe, A. Y. M., Arthur, L. O., & Johnson, R. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1431-1437.1998 · Cited by 224
Schäfer, A., Bogerd, H. P., & Cullen, B. R. (2004) · Virology · doi:10.1016/j.virol.2004.08.006 · Cited by 223
Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.02584-06 · Cited by 223
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G
Chen, K.-M., Harjes, E., Gross, P. J., Fahmy, A., Lu, Y., Shindo, K., Harris, R. S., & Matsuo, H. (2008) · Nature · doi:10.1038/nature06638 · Cited by 221
Russell, R. A., & Pathak, V. K. (2007) · Journal of Virology · doi:10.1128/jvi.00395-07 · Cited by 217
The APOBEC-2 crystal structure and functional implications for the deaminase AID
Prochnow, C., Bransteitter, R., Klein, M. G., Goodman, M. F., & Chen, X. S. (2007) · Nature · doi:10.1038/nature05492 · Cited by 209
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., & Wahl, S. M. (2007) · Blood · doi:10.1182/blood-2006-10-051763 · Cited by 202
Suspene, R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh554 · Cited by 201
Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies
Wichroski, M. J., Robb, G. B., & Rana, T. M. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020041 · Cited by 200
Iwatani, Y., Takeuchi, H., Strebel, K., & Levin, J. G. (2006) · Journal of Virology · doi:10.1128/jvi.02680-05 · Cited by 200
Luo, K., Liu, B., Xiao, Z., Yu, Y., Yu, X., Gorelick, R., & Yu, X.-F. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11841-11852.2004 · Cited by 197
Guo, F., Cen, S., Niu, M., Saadatmand, J., & Kleiman, L. (2006) · Journal of Virology · doi:10.1128/jvi.01038-06 · Cited by 196
APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS
An, P., Bleiber, G., Duggal, P., Nelson, G., May, M., Mangeat, B., Alobwede, I., Trono, D., Vlahov, D., Donfield, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11070-11076.2004 · Cited by 193
Simon, J. H., & Malim, M. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5297-5305.1996 · Cited by 188
Self-citationHuthoff, H., & Malim, M. H. (2007) · Journal of Virology · doi:10.1128/jvi.02795-06 · Cited by 187
Self-citationKozak, S. L., Marin, M., Rose, K. M., Bystrom, C., & Kabat, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601901200 · Cited by 181
Sova, P., & Volsky, D. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6322-6326.1993 · Cited by 180
Luo, K., Xiao, Z., Ehrlich, E., Yu, Y., Liu, B., Zheng, S., & Yu, X.-F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502440102 · Cited by 178
Khan, M. A., Kao, S., Miyagi, E., Takeuchi, H., Goila-Gaur, R., Opi, S., Gipson, C. L., Parslow, T. G., Ly, H., & Strebel, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5870-5874.2005 · Cited by 177
A Zinc-binding Region in Vif Binds Cul5 and Determines Cullin Selection
Mehle, A., Thomas, E. R., Rajendran, K. S., & Gabuzda, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602413200 · Cited by 176
Janini, M., Rogers, M., Birx, D. R., & McCutchan, F. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7973-7986.2001 · Cited by 175
Kieffer, T. L., Kwon, P., Nettles, R. E., Han, Y., Ray, S. C., & Siliciano, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1975-1980.2005 · Cited by 172
GALLO, R., WONG-STAAL, F., MONTAGNIER, L., HASELTINE, W. A., & YOSHIDA, M. (1988) · Nature · doi:10.1038/333504a0 · Cited by 171
7SL RNA Mediates Virion Packaging of the Antiviral Cytidine Deaminase APOBEC3G
Wang, T., Tian, C., Zhang, W., Luo, K., Sarkis, P. T. N., Yu, L., Liu, B., Yu, Y., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.00892-07 · Cited by 162
Kobayashi, M., Takaori‐Kondo, A., Miyauchi, Y., Iwaï, K., & Uchiyama, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500082200 · Cited by 157
Soros, V. B., Yonemoto, W. M., & Greene, W. C. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030015 · Cited by 153
Liu, B., Sarkis, P. T. N., Luo, K., Yu, Y., & Yu, X.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9579-9587.2005 · Cited by 151
Miyagi, E., Opi, S., Takeuchi, H., Khan, M. H., Goila-Gaur, R., Kao, S., & Strebel, K. (2007) · Journal of Virology · doi:10.1128/jvi.01361-07 · Cited by 150
Schumacher, A. J., Haché, G., MacDuff, D. A., Brown, W. L., & Harris, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.02391-07 · Cited by 148
Restriction of Foamy Viruses by APOBEC Cytidine Deaminases
Delebecque, F., Suspène, R., Calattini, S., Casartelli, N., Saı̈b, A., Froment, A., Wain–Hobson, S., Gessain, A., Vartanian, J., & Schwartz, O. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.605-614.2006 · Cited by 147
Kaiser, S. M., & Emerman, M. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.875-882.2006 · Cited by 141
Simon, J. H., Miller, D. L., Fouchier, R. A. M., Soares, M. A., Peden, K., & Malim, M. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1259 · Cited by 140
Self-citationVartanian, J., Meyerhans, A., Sala, M., & Wain–Hobson, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3092 · Cited by 138
Pace, C. S., Keller, J., Nolan, D. A., JAMES, I. R., Gaudieri, S., Moore, C., & Mallal, S. A. (2006) · Journal of Virology · doi:10.1128/jvi.00888-06 · Cited by 132
Derse, D., Hill, S. A., Princler, G. L., Lloyd, P. A., & Heidecker, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609444104 · Cited by 130
Tian, C., Yu, X., Zhang, W., Wang, T., Xu, R., & Yu, X.-F. (2006) · Journal of Virology · doi:10.1128/jvi.80.6.3112-3115.2006 · Cited by 129
Courcoul, M., Patience, C., Gondois‐Rey, F., Blanc, D. F., Harmache, A., Sire, J., Vigne, R., & Spire, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2068-2074.1995 · Cited by 128
Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
Jern, P., Stoye, J. P., & Coffin, J. M. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0030183 · Cited by 122
APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia
Jin, X., Brooks, A., Chen, H., Bennett, R. P., Reichman, R. C., & Smith, H. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11513-11516.2005 · Cited by 119
Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication
Suspène, R., Rusniok, C., Vartanian, J., & Wain–Hobson, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl555 · Cited by 118
Burnett, A. S., & Spearman, P. W. (2007) · Journal of Virology · doi:10.1128/jvi.02237-06 · Cited by 113
Molecular mechanisms of apolipoprotein B mRNA editing
Anant, S., & Davidson, N. O. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00009 · Cited by 111
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates
Zennou, V., & Bieniasz, P. D. (2006) · Virology · doi:10.1016/j.virol.2005.12.035 · Cited by 107
Schröfelbauer, B., Senger, T., Manning, G., & Landau, N. R. (2006) · Journal of Virology · doi:10.1128/jvi.00388-06 · Cited by 104
Opi, S., Kao, S., Goila-Gaur, R., Khan, M. A., Miyagi, E., Takeuchi, H., & Strebel, K. (2007) · Journal of Virology · doi:10.1128/jvi.02694-06 · Cited by 99
Hypermutation of an Ancient Human Retrovirus by APOBEC3G
Lee, Y. N., Malim, M. H., & Bieniasz, P. D. (2008) · Journal of Virology · doi:10.1128/jvi.00751-08 · Cited by 97
Self-citationLand, A. M., Ball, T. B., Luo, M., Pilon, R., Sandstrom, P. A., Embree, J. E., Wachihi, C., Kimani, J., & Plummer, F. A. (2008) · Journal of Virology · doi:10.1128/jvi.01115-08 · Cited by 91
Single-stranded RNA facilitates nucleocapsid: APOBEC3G complex formation
Bogerd, H. P., & Cullen, B. R. (2008) · RNA · doi:10.1261/rna.964708 · Cited by 91
Genetic Control of Retrovirus Susceptibility in Mammalian Cells
Goff, S. P. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.094136 · Cited by 89
Biasin, M., Piacentini, L., Caputo, S. L., Kanari, Y., Magri, G., Trabattoni, D., Naddeo, V., Lopalco, L., Clivio, A., Cesana, E., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511988 · Cited by 89
Khan, M. A., Goila-Gaur, R., Opi, S., Miyagi, E., Takeuchi, H., Kao, S., & Strebel, K. (2007) · Retrovirology · doi:10.1186/1742-4690-4-48 · Cited by 84
Gandhi, S. K., Siliciano, J. D., Bailey, J. R., Siliciano, R. F., & Blankson, J. N. (2007) · Journal of Virology · doi:10.1128/jvi.01533-07 · Cited by 82
Do, H., Vasilescu, A., Diop, G., Thomas Hirtzig, A., Heath, S. C., Coulonges, C., Rappaport, J., Therwath, A., Lathrop, M. G., Matsuda, F., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/426826 · Cited by 79
Jönsson, S., Haché, G., Stenglein, M. D., Fahrenkrug, S. C., Andrésdóttir, V., & Harris, R. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl721 · Cited by 77
Harris, R. S., Sheehy, A. M., Craig, H. M., Malim, M. H., & Neuberger, M. S. (2003) · Nature Immunology · doi:10.1038/ni0703-641 · Cited by 76
Self-citationSwanson, C. M., & Malim, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.005 · Cited by 75
Self-citationA New Type of G→A Hypermutation Affecting Human Immunodeficiency Virus
Fitzgibbon, J. E., Mazar, S., & Dubin, D. T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.833 · Cited by 74
Further Investigation of Simian Immunodeficiency Virus Vif Function in Human Cells
Gaddis, N., Sheehy, A. M., Ahmad, K. M., Swanson, C. M., Bishop, K. N., Beer, B., Marx, P. A., Gao, F., Bibollet‐Ruche, F., Hahn, B. H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12041-12046.2004 · Cited by 70
Self-citationBogerd, H. P., Wiegand, H. L., Doehle, B., & Cullen, B. R. (2007) · Virology · doi:10.1016/j.virol.2007.03.019 · Cited by 68
Cho, S., Drechsler, H., Burke, R. C., Arens, M. Q., Powderly, W. G., & Davidson, N. O. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.2069-2072.2006 · Cited by 67
Dang, Y., Siew, L. M., & Zheng, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708728200 · Cited by 60
Model Structure of Human APOBEC3G
Zhang, K., Mangeat, B., Ortiz, M., Zoete, V., Trono, D., Telenti, A., & Michielin, O. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000378 · Cited by 58
Polymorphisms of CUL5 Are Associated with CD4+ T Cell Loss in HIV-1 Infected Individuals
An, P., Duggal, P., Wang, L. H., O’Brien, S. J., Donfield, S. M., Goedert, J. J., Phair, J., Buchbinder, S., Kirk, G. D., & Winkler, C. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030019 · Cited by 57
Kijak, G. H., Janini, L. M., Tovanabutra, S., Sanders‐Buell, E., Arroyo, M. A., Robb, M. L., Michael, N. L., Birx, D. L., & McCutchan, F. E. (2008) · Virology · doi:10.1016/j.virol.2008.03.017 · Cited by 54
Target Cell APOBEC3C Can Induce Limited G-to-A Mutation in HIV-1
Bourara, K., Liegler, T. J., & Grant, R. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030153 · Cited by 54
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
Anderson, J. L., & Hope, T. J. (2008) · Virology · doi:10.1016/j.virol.2008.01.042 · Cited by 51
Langlois, M., & Neuberger, M. S. (2008) · Journal of Virology · doi:10.1128/jvi.02469-07 · Cited by 49
T Cells Contain an RNase-Insensitive Inhibitor of APOBEC3G Deaminase Activity
Thielen, B. K., Klein, K. C., Walker, L. W., Rieck, M., Buckner, J. H., Tomblingson, G. W., & Lingappa, J. R. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030135 · Cited by 46
Doehle, B., Bogerd, H. P., Wiegand, H. L., Jouvenet, N., Bieniasz, P. D., Hunter, E., & Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.01600-06 · Cited by 34
Knoepfel, S. A., Salisch, N. C., Huelsmann, P. M., Rauch, P., Walter, H., & Metzner, K. J. (2008) · Journal of Virology · doi:10.1128/jvi.00554-08 · Cited by 17
Cited by
Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00878-2 · Cited by 1,179
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
Quasispecies Theory and the Behavior of RNA Viruses
Lauring, A. S., & Andino, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001005 · Cited by 846
Evidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
HIV Restriction Factors and Mechanisms of Evasion
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 487
Self-citation
Metadata
- Authors
- Malim, M. H.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2008-11-27
- Volume
- 364
- Issue
- 1517
- Pages
- 675-687
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2107551331
- Cited by
- 280
- References
- 135
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.